688382 益方生物
按盤價 
21.530 -0.530 (-2.403%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.927 | -18.935 | -12.614 | -13.482 | -33.344 |
| 總資產報酬率 ROA (%) | -2.685 | -17.484 | -11.766 | -12.593 | -30.718 |
| 投入資產回報率 ROIC (%) | -2.880 | -18.640 | -12.326 | -13.184 | -32.699 | 邊際利潤分析 |
| 銷售毛利率 (%) | 96.172 | 86.543 | 97.675 | 100.000 | -- |
| 營業利潤率 (%) | -104.036 | -849.091 | -142.309 | -153.064 | -- |
| 息稅前利潤/營業總收入 (%) | -114.449 | -909.756 | -160.553 | -171.402 | -- |
| 淨利潤/營業總收入 (%) | -104.289 | -849.742 | -142.309 | -153.064 | -- | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.409 | 99.888 | 100.447 | 100.127 | 99.987 |
| 價值變動淨收益/利潤總額(%) | -1.626 | -1.071 | -0.541 | -2.310 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.001 | 0.000 | 0.000 | 0.037 | 償債能力分析 |
| 流動比率 (X) | 17.360 | 11.089 | 20.784 | 13.414 | 20.407 |
| 速動比率 (X) | 17.360 | 11.089 | 20.784 | 13.414 | 20.407 |
| 資產負債率 (%) | 6.579 | 9.844 | 5.728 | 7.616 | 5.661 |
| 帶息債務/全部投入資本 (%) | 0.458 | 0.427 | 0.398 | 2.685 | 0.519 |
| 股東權益/帶息債務 (%) | 21,485.427 | 23,028.984 | 24,778.293 | 3,612.726 | 18,978.022 |
| 股東權益/負債合計 (%) | 1,420.076 | 915.824 | 1,645.658 | 1,213.098 | 1,666.552 |
| 利息保障倍數 (X) | 10.991 | 14.999 | 8.800 | 9.347 | 14.381 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 224.430 | 1,206.808 | 364.614 | 342.611 | -- |
| 存貨周轉天數 (天) | 0.000 | 0.000 | 0.000 | -- | -- |
| 備註： | 即時報價更新時間為 15/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
